← ACM Research, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $1.0m |
($318k)
-130.84%
|
$6.6m
+2167.30%
|
$18.9m
+187.40%
|
$18.8m
-0.60%
|
$37.8m
+101.05%
|
$39.3m
+3.99%
|
$77.3m
+97.00%
|
$103.6m
+33.97%
|
$94.1m
-9.21%
|
— | |
| Net Income (Loss) Available to Common Stockholders, Basic | $645k |
($318k)
-149.30%
|
$6.6m
+2167.30%
|
$19.5m
+195.98%
|
$21.7m
+11.40%
|
$37.8m
+74.18%
|
$39.3m
+3.99%
|
$77.3m
+97.00%
|
$103.6m
+33.97%
|
$94.1m
-9.21%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $2.4m | ($872k) | $6.6m | $19.5m | $21.7m | $42.9m | $50.6m | $96.9m | $131.3m | $121.9m | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.4m | ($554k) | $0 | — | $2.9m | $5.2m | $11.3m | $19.5m | $27.6m | $27.8m | — | |
| Depreciation, Depletion and Amortization | $187k | $271k | $417k | $788k | $1.1m | $2.4m | $5.4m | $8.1m | $6.6m | $14.4m | $21.7m | |
| Amortization | — | — | — | — | — | $199k | — | — | — | — | — | |
| Depreciation | $180k | $243k | $350k | $713k | $826k | $2.1m | $4.8m | $6.9m | $10.0m | $16.3m | $21.7m | |
| Deferred Income Tax Expense (Benefit) | — | — | ($405k) | ($3.7m) | ($4.1m) | ($1.8m) | $5.2m | ($13.2m) | $5.4m | ($15.0m) | ($2.7m) | |
| Deferred Other Tax Expense (Benefit) | — | — | — | ($4.0m) | — | — | — | — | — | — | — | |
| Share-based Payment Arrangement, Noncash Expense | $383k | $1.6m | $3.4m | $3.6m | $5.6m | $5.1m | $7.7m | $27.3m | $49.6m | $33.6m | $26.2m | |
| Share-based Payment Arrangement, Expense | — | — | — | — | $5.6m | $5.1m | $7.7m | $27.3m | $49.6m | $33.6m | $26.2m | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | $0 | — | — | — | — | |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | — | — | — | — | — | — | $1.1m | $9.0m | $1.8m | $166k | — | |
| Income (Loss) from Equity Method Investments | $0 | $37k | $123k | $168k | $655k | $4.6m | $4.7m | $10.0m | $423k | $10.3m | — | |
| Other Nonoperating Income (Expense) | — | — | — | $1.4m | ($3.4m) | ($631k) | $3.3m | ($1.6m) | $6.3m | ($9.8m) | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | — | — | — | $7.0m | $22.1m | $47.6m | $88.7m | $108.7m | $123.3m | $116.1m | ($85.7m) | |
| Increase (Decrease) in Inventories | $3.1m | $3.1m | $24.1m | $6.7m | $40.8m | $127.7m | $193.3m | $164.0m | $64.1m | $108.2m | ($125.2m) | |
| Inventory Write-down | — | — | — | — | — | — | $2.2m | $575k | $3.1m | $15.5m | — | |
| Increase (Decrease) in Accounts Payable | $3.2m | $1.9m | $9.8m | ($3.1m) | $21.3m | $65.2m | $17.5m | $42.3m | $1.4m | $67.9m | $59.4m | |
| Net Cash Provided by (Used in) Operating Activities | ($3.7m) |
($8.1m)
-118.83%
|
$6.9m
+185.29%
|
$9.4m
+36.10%
|
($13.5m)
-244.07%
|
($40.1m)
-195.95%
|
($62.2m)
-55.12%
|
($75.3m)
-21.11%
|
$152.4m
+302.40%
|
($10.3m)
-106.77%
|
($6.6m)
+36.06%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $795k | $651k | $1.8m | $971k | $5.2m | $9.2m | $91.1m | $61.9m | $82.5m | $56.3m | ($113.2m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | — | $0 | ($294k) | ($25k) | $0 | $12k | $2k | ($945k) | $33k | ($24.3m) | |
| Debt Securities, Trading, Gain (Loss) | — | — | — | — | — | — | — | — | $2.8m | $17.6m | — | |
| Gain (Loss) on Sale of Investments | — | — | $0 | $0 | ($12.6m) | ($607k) | $7.9m | $2.7m | ($973k) | $112k | — | |
| Marketable Securities, Unrealized Gain (Loss) | — | — | $0 | $0 | $12.6m | $607k | ($7.9m) | ($2.7m) | $973k | $17.5m | — | |
| Net Cash Provided by (Used in) Investing Activities | ($810k) | ($23.7m) | ($2.1m) | ($5.5m) | ($70.0m) | ($11.3m) | ($265.7m) | ($6.7m) | ($12.0m) | ($390.3m) | ($438.5m) | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | — | — | — | — | — | — | — | — | $9.6m | $60.3m | ($107.9m) | |
| Proceeds from Issuance of Long-term Debt | — | — | — | — | $19.7m | $7.1m | $0 | $42.4m | $96.9m | $119.1m | $105.2m | |
| Payments for Repurchase of Common Stock | — | — | — | $2.8m | $0 | $0 | — | — | — | — | — | |
| Proceeds from Issuance of Common Stock | $0 | $18.7m | $0 | $26.4m | $0 | $0 | — | — | — | — | $881.6m | |
| Net Cash Provided by (Used in) Financing Activities | $10.6m |
$38.7m
+266.88%
|
$5.1m
-86.77%
|
$87.4m
+1606.91%
|
$32.8m
-62.45%
|
$538.8m
+1540.88%
|
$45.9m
-91.49%
|
$18.5m
-59.60%
|
$92.5m
+399.09%
|
$742.5m
+702.85%
|
$964.1m
+29.85%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | ($518k) | $90.7m | ($46.1m) | $491.3m | ($314.6m) | ($65.3m) | $228.1m | $354.7m | $971.9m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | ($518k) | $117.9m | $71.8m | $563.1m | $248.5m | $183.2m | $411.3m | $766.0m | $971.9m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | ($518k) | ($582k) | $4.6m | $3.9m | ($32.6m) | ($1.7m) | ($4.8m) | $12.8m | $18.7m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $181k | $277k | $498k | $745k | $982k | $765k | $1.7m | $2.7m | $4.2m | $7.0m | — | |
| Income Taxes Paid, Net | — | — | $0 | $1.2m | $5.0m | $1.1m | $3.6m | $26.1m | $11.2m | $32.4m | — | |
| Additional Financial Items | ||||||||||||
| Gain (Loss) on Disposition of Assets for Financial Service Operations | ($3k) | ($1k) | $0 | — | — | — | — | — | — | — | — | |
| General and Administrative Expense | $2.7m | $5.9m | $8.0m | $8.1m | $12.2m | $15.2m | $22.5m | $40.6m | $69.6m | $68.8m | — | |
| Income Tax Expense (Benefit) | $595k | $547k | $806k | ($518k) | ($2.4m) | $134k | $16.8m | $19.4m | $35.0m | $13.3m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $4.2m | $7.0m | — | |
| Investment Income, Interest | $16k | $9k | $29k | $333k | $897k | $505k | $8.7m | $8.4m | $9.9m | $14.6m | — | |
| Operating Expenses | $9.8m | $16.5m | $28.0m | $32.9m | $48.1m | $76.2m | $124.6m | $180.4m | $240.6m | $290.6m | — | |
| Proceeds from Noncontrolling Interests | — | — | — | $59.7m | $0 | $0 | — | — | — | $242k | — | |
| Proceeds from Stock Options Exercised | $410k | $396k | $528k | $317k | $2.7m | $3.4m | $1.3m | $6.1m | $11.1m | $34.8m | — |